多囊卵巢
高雄激素血症
肌醇
医学
内分泌学
芳香化酶
妇科
内科学
无排卵
作者
Antonio Cianci,Salvatore Giovanni Vitale
标识
DOI:10.1080/09637486.2022.2029830
摘要
Polycystic ovary syndrome (PCOS) is one of the most common disorders among women of reproductive age and can be diagnosed when at least two of the following criteria are present: chronic ovulatory disorder, clinical and/or biochemical hyperandrogenism, and polycystic ovaries. Diet and lifestyle modifications are the main therapeutic intervention and they can fully restore ovary function and avoid PCOS consequences in a certain number of patients. However, prescription of medications or dietary supplements is often needed. The literature has confirmed the significant role of inositol therapy in PCOS, with particular reference to Myo-inositol and D-chiro-Inositol. The aim of this review is to clarify the use of inositols for the treatment of PCOS and the recent scientific theories about D-Chiro-Inositol properties as an ovarian aromatase inhibitor.
科研通智能强力驱动
Strongly Powered by AbleSci AI